Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21399
Title: Genomics for molecular epidemiology and detecting transmission of carbapenemase-producing Enterobacterales in Victoria, Australia, 2012-2016.
Austin Authors: Sherry, Norelle L ;Lane, Courtney R;Kwong, Jason C ;Schultz, Mark;Sait, Michelle;Stevens, Kerrie;Ballard, Susan;Gonçalves da Silva, Anders;Seemann, Torsten;Gorrie, Claire L;Stinear, Timothy P;Williamson, Deborah A;Brett, Judith;van Diemen, Annaliese;Easton, Marion;Howden, Benjamin P 
Affiliation: Antimicrobial Reference and Research Unit, Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
Victorian Healthcare Associated Infection Surveillance Coordinating Centre, Melbourne, Australia
Health Protection Branch, Department of Health and Human Services, Victorian State Government, Melbourne, Australia
Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia
Issue Date: 26-Aug-2019
metadata.dc.date: 2019-07-17
Publication information: Journal of clinical microbiology 2019; 57(9): e00573-19
Abstract: Background Carbapenemase-producing Enterobacterales (CPE) are being increasingly reported in Australia, and integrated clinical and genomic surveillance is critical to effectively manage this threat. We sought to systematically characterize CPE in Victoria, Australia from 2012-2016. Methods Suspected CPE were referred to the state public health laboratory in Victoria, Australia from 2012-2016, and examined using phenotypic, multiplex PCR, and whole genome sequencing (WGS) methods, and compared with epidemiological metadata. Results Carbapenemase genes were detected in 361 isolates from 291 patients (30.8% of suspected CPE isolates), mostly from urine (42.1%) or screening samples (34.8%). IMP-4 (28.0% of patients), KPC-2 (25.3%), NDM (24.1%) and OXA carbapenemases (22.0%) were most common; Klebsiella pneumoniae (48.8% of patients) and Escherichia coli (26.1%) were the dominant species. Carbapenemase-inactivation method (CIM) testing reliably detected carbapenemase-positive isolates (100% sensitivity, 96.9% specificity), identifying an additional five CPE amongst 159 PCR-negative isolates (IMI and SME carbapenemases).When epidemiologic investigations were performed, all pairs of patients designated 'highly likely' or 'possible' local transmission had ≤23 pairwise single-nucleotide polymorphisms (SNPs) by genomic transmission analysis; conversely, all patient pairs designated 'highly unlikely' local transmission had ≥26 pairwise SNPs. Using this proposed threshold, possible local transmission was identified involving a further 16 patients for whom epidemiologic data was unavailable. Conclusions Systematic application of genomics has uncovered the emergence of polyclonal CPE as a significant threat in Australia, providing important insights to inform local public health guidelines and interventions. Using our workflow, pairwise SNP distances between CPE isolates of ≤23 SNPs suggests local transmission.
URI: http://ahro.austin.org.au/austinjspui/handle/1/21399
DOI: 10.1128/JCM.00573-19
ORCID: 0000-0002-7689-6531
0000-0001-6046-610X
0000-0003-0150-123X
0000-0003-0237-1473
0000-0002-7789-8360
PubMed URL: 31315956
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

8
checked on Nov 29, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.